MA45027B1 - Polynucléotides codant pour l'interleukine 12 (il-12) et leurs utilisations - Google Patents
Polynucléotides codant pour l'interleukine 12 (il-12) et leurs utilisationsInfo
- Publication number
- MA45027B1 MA45027B1 MA45027A MA45027A MA45027B1 MA 45027 B1 MA45027 B1 MA 45027B1 MA 45027 A MA45027 A MA 45027A MA 45027 A MA45027 A MA 45027A MA 45027 B1 MA45027 B1 MA 45027B1
- Authority
- MA
- Morocco
- Prior art keywords
- sequence
- polynucleotides
- polynucleotides encoding
- optimized
- encoding interleukin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/208—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/7115—Nucleic acids or oligonucleotides having modified bases, i.e. other than adenine, guanine, cytosine, uracil or thymine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
- A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5434—IL-12
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Mycology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
La présente invention concerne des polynucléotides comprenant un cadre de lecture ouvert de nucléosides liés codant pour l'interleukine 12 (il-12) humaine, des fragments fonctionnels de ceux-ci, et des protéines de fusion comprenant il-12. Dans certains modes de réalisation, le cadre de lecture ouvert est optimisé en séquence. Dans des modes de réalisation particuliers, l'invention concerne des polynucléotides à séquence optimisée comprenant des nucléotides codant pour la séquence polypeptidique de l'il-12 humaine, ou des séquences ayant une identité de séquence élevée avec ces polynucléotides à séquence optimisée.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662338483P | 2016-05-18 | 2016-05-18 | |
PCT/US2017/033422 WO2017201350A1 (fr) | 2016-05-18 | 2017-05-18 | Polynucléotides codant pour l'interleukine 12 (il-12) et leurs utilisations |
Publications (2)
Publication Number | Publication Date |
---|---|
MA45027A MA45027A (fr) | 2019-03-27 |
MA45027B1 true MA45027B1 (fr) | 2023-02-28 |
Family
ID=85793851
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA45027A MA45027B1 (fr) | 2016-05-18 | 2017-05-18 | Polynucléotides codant pour l'interleukine 12 (il-12) et leurs utilisations |
Country Status (1)
Country | Link |
---|---|
MA (1) | MA45027B1 (fr) |
-
2017
- 2017-05-18 MA MA45027A patent/MA45027B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
MA45027A (fr) | 2019-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022008602A (es) | Polinucleotidos que codifican interleucina-12 (il 12) y usos de los mismos. | |
MX2021003765A (es) | Proteínas il-12 de fusión a fc heterodimérico. | |
WO2022087149A3 (fr) | Protéines de fusion d'interleukine-2-fc et méthodes d'utilisation | |
PH12020551671A1 (en) | Chimeric receptors to dll3 and methods of use thereof | |
ECSP066297A (es) | Anticuerpos contra interleucina 22 y usos de los mismos | |
PE20170503A1 (es) | Proteinas de fusion de interleucina 2/receptor de interleucina-2 alfa y metodos de uso | |
IL171356A (en) | Anti-interferon receptor antibody for treatment of inflammatory bowel disease | |
PH12020551019A1 (en) | IL-22 Fc FUSION PROTEINS AND METHODS OF USE | |
MX2019000898A (es) | Amortiguador de lavado de cromatografia de afinidad. | |
WO2005021592A3 (fr) | Augmentation de la demi-vie circulante de proteines de type interleukine 2 | |
PH12018501025A1 (en) | Improved tnf binders | |
DE602005022056D1 (de) | Polypeptidsequenzen, die an der modulation des immunsupppressiven effekts viraler proteine beteiligt sind | |
EA200801174A1 (ru) | Антитела-миметики glp-2, полипептиды, композиции, способы и применения | |
MA45172B1 (fr) | Arn modifié codant pour des polypeptides vegf-a, formulations et utilisations associées | |
PH12020551492A1 (en) | Anti-dengue virus antibodies having cross-reactivity to zika virus and methods of use | |
MX2021012047A (es) | Polipeptidos de fusion de serpina y metodos para utilizar los mismos. | |
CY1114526T1 (el) | Κατασταλτικες πρωτεϊνες μιας πρωτεασης (protease) και χρησεις αυτων | |
EA201992776A1 (ru) | Белки на основе антитела с привитым цитокином и способы их применения при иммунных нарушениях | |
MX2023001256A (es) | Proteínas que comprenden dominios de unión al antígeno hla-g y sus usos. | |
JOP20210011A1 (ar) | مستقبلات خيمرية لـ steap1 وطرق استخدامها | |
IS7746A (is) | Meðferðir á þrálátum bólgutengdum afmýlunarfjöltaugakvilla með því að nota beta interferon | |
MY197491A (en) | Identification of mutations in channelopsin variants having improved light sensitivity and methods of use thereof | |
MA45027B1 (fr) | Polynucléotides codant pour l'interleukine 12 (il-12) et leurs utilisations | |
FR3001729B1 (fr) | Mutants du facteur x | |
ATE461999T1 (de) | Detektion von verkürzungsmutationen durch massenspektrometrie |